Your browser doesn't support javascript.
loading
Development of a predictive model to distinguish prostate cancer from benign prostatic hyperplasia by integrating serum glycoproteomics and clinical variables.
Gabriele, Caterina; Aracri, Federica; Prestagiacomo, Licia Elvira; Rota, Maria Antonietta; Alba, Stefano; Tradigo, Giuseppe; Guzzi, Pietro Hiram; Cuda, Giovanni; Damiano, Rocco; Veltri, Pierangelo; Gaspari, Marco.
  • Gabriele C; Research Centre for Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy. cgabriele86@gmail.com.
  • Aracri F; Department of Surgical and Medical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Prestagiacomo LE; Research Centre for Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Rota MA; Romolo Hospital, Rocca Di Neto, Italy.
  • Alba S; Romolo Hospital, Rocca Di Neto, Italy.
  • Tradigo G; Ecampus University, Novedrate, Italy.
  • Guzzi PH; Department of Surgical and Medical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Cuda G; Research Centre for Advanced Biochemistry and Molecular Biology, Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Damiano R; Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Veltri P; Department of Surgical and Medical Sciences, Magna Graecia University of Catanzaro, Catanzaro, Italy.
  • Gaspari M; Department of Computer Engineering, Modeling, Electronics and Systems, University of Calabria, 87036 Rende, Italy.
Clin Proteomics ; 20(1): 52, 2023 Nov 21.
Article en En | MEDLINE | ID: mdl-37990292